AC Immune (ACIU) Asset Utilization Ratio (2016 - 2026)
AC Immune's (ACIU) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2026, down 99.96% year-on-year from 0.13 in Q1 2025, and down 99.75% on a QoQ basis from 0.02 in Q4 2025.
AC Immune (ACIU) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
AC Immune (ACIU) has 8 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 99.96% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 99.96% decrease from a year earlier, with the FY2025 full-year figure at 0.02, down 85.56% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.0, down from 0.02 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for ACIU reached as high as 0.14 in Q2 2025 and fell as low as 0.0 in Q1 2026.
- Historically, Asset Utilization Ratio has averaged 0.08 across 4 years, with a median of 0.07 in 2022.
- Across the five-year window, Asset Utilization Ratio soared 362.41% in 2025 and sank 99.96% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.07 in 2022, then soared by 86.77% to 0.13 in 2024, then slumped by 83.88% to 0.02 in 2025, then sank by 99.75% to 0.0 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q1 2026, 0.02 in Q4 2025, and 0.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.03 |
| Sep 30, 2022 | 0.07 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.06 |
| Jun 30, 2020 | 0.06 |
| Mar 31, 2020 | 0.06 |
| Dec 31, 2019 | 0.26 |
| Sep 30, 2019 | 0.00 |
| Jun 30, 2019 | 0.00 |
| Mar 31, 2019 | 0.32 |
| Mar 31, 2017 | 13.37 |
| Dec 31, 2016 | 0.11 |